Medtronic, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 108   

Articles published

MDT 58.55 +0.06 (0.10%)
price chart
Medtronic Prevented From Selling Heart Valve In US
Medtronic is appealing the ruling, but for now has stopped training new doctors in how to use the devices, and told surgeons already using the valves not to schedule any new procedures, the company said.
Medtronic Down After Court Halts Sales Of Heart Valve System
Shares of medical device maker Medtronic Inc fell as much as 6 percent after a U.S. court temporarily halted sales of its aortic heart valve replacement system in the country.
Edwards shares up on injunction against Medtronic heart valve  Reuters
Related articles »  
Medtronic takes majority interest in Biostar, a med-tech distributor in Turkey
Medtronic Inc. said Monday that it has acquired a majority interest in Biostar, a joint venture that will distribute the medical device giant's products in Turkey.
Related articles »  
Better Buy: Medtronic, Inc. vs. Edwards Lifesciences Corp.
However, it was Medtronic (NYSE: MDT ) , the industry medical device giant, that put up the most noteworthy news this year when it unleashed data showing that patients receiving its CoreValve transcatheter through a minimally invasive procedure did ...
Medtronic Inc. Barred from Selling Artificial Heart Valve to Most Patients in ...
Apr 15, 2014 (ACCESSWIRE via COMTEX) -- Medtronic, Inc. (NYSE:MDT) - For an in-depth report on Medtronic, Inc. follow Shares of Medtronic closed down a modest 1.89% on Monday with nearly 10.5 million shares ...
Related articles »  
Will This Downgrade Hurt Medtronic (MDT) Stock Today?
"We rate MEDTRONIC INC (MDT) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
Insider Selling: Richard Kuntz Sells 2512 Shares of Medtronic Stock (MDT)  Zolmax
Related articles »  
Medtronic (MDT) Down In Pre-Market Trading
Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group.
Medtronic, Inc. Slumps After Injunction On Heart Valve Sales
Medtronic, Inc. (NYSE:MDT) shares were off by 5% in early trading today after a federal court placed a temporary injunction on sales of its aortic heart valve replacement system in the U.S.
Related articles »  
Edwards Lifesciences Gain, Medtronic in Pain
The court granted Edwards Lifesciences a preliminary injunction blocking sales of Medtronic, Inc.'s (MDT - Analyst Report) CoreValve in the U.S.. An Insight into the Patent Battle. Edward's Lifesciences had initiated this case in 2008. On Mar 19, 2010 ...
UPDATE 1-Survival rate with Medtronic's CoreValve tops surgery -study
WASHINGTON, March 29 (Reuters) - Medtronic Inc's minimally invasive CoreValve system for replacing diseased aortic heart valves led to a significantly higher survival rate after one year than traditional open heart surgery in patients deemed at high ...
Edwards Valve Outperforms Medtronic's in First Comparison (1)  Businessweek
CoreValve system of Medtronic Inc posts high survival rate than traditional ...  Venture Capital Post
Related articles »